CN Patent
CN101365423A — 缓释小分子药物制剂
Assigned to Alza Corp · Expires 2009-02-11 · 17y expired
What this patent protects
本发明涉及缓释小分子药物制剂。本发明提供了一种可注射的长效制剂,所述制剂包含生物相容性聚合物、与所述生物相容性聚合物结合以形成粘性凝胶的有机溶剂以及掺入所述粘性凝胶中的小分子药物,从而使得所述制剂显示出C max 与C mix 之比小于200且滞后时间小于0.2的体内释放曲线。
USPTO Abstract
本发明涉及缓释小分子药物制剂。本发明提供了一种可注射的长效制剂,所述制剂包含生物相容性聚合物、与所述生物相容性聚合物结合以形成粘性凝胶的有机溶剂以及掺入所述粘性凝胶中的小分子药物,从而使得所述制剂显示出C max 与C mix 之比小于200且滞后时间小于0.2的体内释放曲线。
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.